Sierra Oncology, Inc. - stock earnings

SRRA Quarterly earnings

DateEarningsRevenue
2021Q4 -25.5 million USD ? USD
2021Q3 -28.6 million USD ? USD
2021Q2 -20.6 million USD ? USD
2021Q1 -19.9 million USD ? USD
2020Q4 -18.0 million USD 200000 USD
2020Q3 -14.5 million USD 100000 USD

SRRA Yearly earnings

DateEarningsRevenue
2021 -94.7 million USD ? USD
2020 -80.9 million USD 300000 USD
2019 -88.3 million USD ? USD
2018 -53.3 million USD ? USD
2017 -42.0 million USD ? USD

SRRA

Price: $54.99

52 week price:
14.91
55.19

Earnings Per Share: -4.89 USD

P/E Ratio: -1.06

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 858299

Ebitda: -10.1 million

Market Capitalization: 827.9 million

Links: